| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.LFS.2006.01.043 |
| P698 | PubMed publication ID | 16516241 |
| P50 | author | Victor E Laubach | Q50277683 |
| Weibin Shi | Q56877222 | ||
| Aldons Jake Lusis | Q60642067 | ||
| Alan H Matsumoto | Q63001754 | ||
| P2093 | author name string | Xuping Wang | |
| Diana M Shih | |||
| Yuhua Li | |||
| Toru Miyoshi | |||
| Gregory A Helm | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 525-531 | |
| P577 | publication date | 2006-03-03 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice | |
| P478 | volume | 79 |
| Q26745608 | Altered Nitric Oxide System in Cardiovascular and Renal Diseases |
| Q35116630 | Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk |
| Q38397635 | Antidiabetic agents and endothelial dysfunction - beyond glucose control |
| Q41989452 | Circulating anti-beta2-glycoprotein I antibodies are associated with endothelial dysfunction, inflammation, and high nitrite plasma levels in patients with intermittent claudication |
| Q37184304 | Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides |
| Q92420811 | Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? |
| Q37078664 | Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice |
| Q37360401 | Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells |
| Q34150541 | Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli |
| Q39191329 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q28486286 | Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts |
| Q52867583 | Insulin decreases atherosclerotic plaque burden and increases plaque stability via nitric oxide synthase in apolipoprotein E-null mice. |
| Q80055459 | L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits |
| Q36982646 | Long-term pleiotropic effect of statins upon nitric oxide and C-reactive protein levels in patients with peripheral arterial disease |
| Q92215652 | Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease |
| Q33554184 | Oxidative risk for atherothrombotic cardiovascular disease |
| Q33673046 | P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice |
| Q36026137 | Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis |
| Q35165194 | Reactive oxygen species in cardiovascular disease. |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q46305715 | Regulation and function of endothelial glycocalyx layer in vascular diseases |
| Q35121079 | Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure |
| Q36666637 | Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases |
| Q52621951 | Roles for Endothelial Cell and Macrophage Gch1 and Tetrahydrobiopterin in Atherosclerosis Progression. |
| Q33710782 | Sex-Related Difference in Nitric Oxide Metabolites Levels after Nephroprotectant Supplementation Administration against Cisplatin-Induced Nephrotoxicity in Wistar Rat Model: The Role of Vitamin E, Erythropoietin, or N-Acetylcysteine |
| Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
| Q54854556 | The role of tetrahydrobiopterin in inflammation and cardiovascular disease. |
| Q35893272 | Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano) |
Search more.